SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors react to a clinical trial update confirming 78 events in the pivotal REGAL study, bringing the company closer to the 80-event trigger for data unblinding. Community sentiment is highly polarized, with intense debate over the timing of final results, the company's strong cash position, and widespread speculation regarding potential buyout interest from big pharma.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors weigh its recent regulatory win, involving the approval of its reactor design criteria, against concerns regarding its pre-revenue status and significant insider share sales. While the community is actively debating the company's long-term potential as a critical energy provider for AI data centers, sentiment remains divided between those betting on government-backed expansion and those skeptical of the current valuation.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense momentum as the community discusses a potential gamma and short squeeze, driven by its critical role in the growing Edge AI and data center memory sectors. Investors are actively debating the sustainability of the rally, with many comparing it to previous memory sector winners while keeping a close eye on float constraints and institutional interest.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing intense volatility and downward pressure as investors grow skeptical of management's ability to convert defense partnerships and production capacity into immediate financial results ahead of the upcoming earnings release. The community remains divided, with some betting on a potential short squeeze fueled by significant short interest, while critics express frustration over the gap between the company's ambitious narrative and its historical revenue performance.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing intensified market speculation driven by community discussions around potential data center storage partnerships and its role in defense-related battery applications. While investors remain eager for concrete news on production scale, the active trading sentiment is fueled by institutional positioning and high option volume, with many focusing on the company's long-term potential as an energy storage leader.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendys is trending as investors react to reports that Nelson Peltzs Trian Fund Management is seeking financing for a potential take-private bid, fueling community speculation about a significant short squeeze. Many participants are debating the viability of a buyout valuation while closely monitoring high short interest and the stocks historical trading patterns.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology Group Ltd (WOK) continues to experience extreme volatility and intense retail attention following rapid price swings that have drawn comparisons to high-momentum Chinese stock runners. The community remains divided between day traders seeking aggressive squeeze opportunities and skeptics citing concerns over the company's financial fundamentals and historical pattern of dilutive offerings.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate whether the current price represents a deep-value opportunity or a value trap, with the community closely tracking its pivot into agentic AI orchestration and enterprise integration partnerships. While some participants express frustration over persistent share price weakness and perceived manipulation, others are aggressively accumulating shares, pointing to the company's strong cash position, lack of debt, and potential for long-term growth as the market rotates toward quality AI software.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is gaining significant attention as investors react to its emergence as a specialized AI infrastructure play, bolstered by strategic partnerships with major tech giants and a strong performance in recent financial reports. Community members are actively debating the company's long-term potential, focusing on its role in critical AI data center scaling, its memory technology solutions, and whether the stock's current valuation offers a deep-value opportunity compared to other sector leaders.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending following a significant legal move to rescind its distribution agreement with Nippon Shinyaku, with investors viewing the challenge as a strategic step to regain control over commercialization ahead of an anticipated product approval. The community is actively discussing the potential for a more lucrative partnership or independent launch, fueling optimism that the company is clearing obstacles to capture the full value of its DMD therapy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BLUE WATER ACQUISITION CORP. IV ANNOUNCES LETTER OF INTENT FOR A PROPOSED ACQUISITION OF MAHA CAPITAL AB SUBSIDIARIES, CREATING A PUBLIC PLATFORM WITH VENEZUELAN ENERGY EXPOSURE AND HIGH-GROWTH AI FINTECH BUSINESS

BLUE WATER ACQUISITION CORP. IV ANNOUNCES LETTER OF INTENT FOR A PROPOSED ACQUISITION OF MAHA CAPITAL AB SUBSIDIARIES, CREATING A PUBLIC PLATFORM WITH VENEZUELAN ENERGY EXPOSURE AND HIGH-GROWTH AI...

NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade

NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade NYSE Content Update: Versigent To Ring Opening Bell As its Shares Debut for Trade PR Newswire NEW YORK, April 1, 2026...

Joseph Hernandez, Chairman and CEO, to Ring NYSE Closing Bell Following $130 Million IPO of Blue Water Acquisition Corp. IV

Joseph Hernandez, Chairman and CEO, to Ring NYSE Closing Bell Following $130 Million IPO of Blue Water Acquisition Corp. IV Joseph Hernandez, Chairman and CEO, to Ring NYSE Closing Bell Following...

Blue Water Acquisition Corp. IV operates as a blank check company. Its purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 1, 2025 and is headquartered in Greenwich. CT.

BWIV
Blue Water Acquisition Corp IV - Ordinary Shares - Class A

Feed

News

Sentiment

Fundamentals

Info

Latest BWIV News

BWIVBlue Water Acquisition Corp IV - Ordinary Shares - Class A